Chronic treatment with MifaMurtide significantly increased RANK mRNA expression in MG63 monocultures compared with MG63 alone. In BMDMs undergoing RANKL- and M-CSF-induced differentiation, MifaMurtide significantly reduced mature osteoclasts, with their number inversely related to MifaMurtide concentration. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
RANK Expression in MG63 Monocultures
Cell-based study · Monocultures of MG63 [1]
MG63 monocultures treated chronically with MifaMurtide showed a significant increase in RANK mRNA expression compared with MG63 alone.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 µM
- Exposure duration
- treated chronically with Mifamurtide [100 µM] for 7 days
- Method
- used in culture
- Vehicle
- sterile water
Methods and source locations
Compound reported in the paper: MifaMurtide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Mifamurtide modulates osteoblast markers (S9); MATERIALS AND METHODS > Cell cultures (S24); MATERIALS AND METHODS > Drugs (S66); Figure 4 legend (S101, S103)
RANK mRNA expression levels: RANK mRNA expression levels; comparator: MG63 alone — RESULTS > Mifamurtide modulates osteoblast markers (S9); MATERIALS AND METHODS > Cell cultures (S24); Figure 4 legend (S101)
Osteoclast Differentiation in BMDMs
Cell-based study · BMDMs [2]
BMDMs undergoing osteoclast differentiation induced with RANKL and M-CSF were treated with different concentrations of MifaMurtide. Mature osteoclasts were significantly reduced, and their number was inversely related to MifaMurtide concentration.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0, 50, 5000 nM
- Exposure duration
- 5 days
- Co-treatment
- Other interventions in this design: RANKL 40 ng/ml; M-CSF 10 ng/ml. Compound effect isolated by the comparison: different concentrations of mifamurtide (0, 50, 5000 nM).
- Reported limits
- Not stated in the sentences used: route, vehicle.
Methods and source locations
Compound reported in the paper: MifaMurtide
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Pharmacological inhibition of Irgm1 alleviates OVX-induced osteoporosis (S220); Fig. 8 legend (S357, S359)
Quantitative analysis of TRAP-positive MNCs: Quantitative analysis of TRAP-positive MNCs; comparator: 0 nM — Results > Pharmacological inhibition of Irgm1 alleviates OVX-induced osteoporosis (S220); Fig. 8 legend (S357, S359)